BetaVet® is indicated for the control of pain and inflammation associated with osteoarthritis in horses.
IMPORTANT SAFETY INFORMATION
For Intra-Articular (I.A.) use in Horses.
BetaVet® is contraindicated in horses with hypersensitivity to betamethasone.
Intra-articular injection of corticosteroids for local effect is contraindicated in the presence of septic arthritis.
Do not use in horses intended for human consumption.
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to
animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature
parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs,
rabbits and rodents during pregnancy have resulted in cleft palate in offspring and in other congenital anomalies including deformed
forelegs, phocomelia and anasarca. Therefore, before use of corticosteroids in pregnant animals, the possible benefits to the pregnant
animal should be weighed against potential hazards to its developing embryo or fetus.
Human Warnings: Not for use in humans. For use in animals only. Keep this and all medications out of the reach of children.
Consult a physician in the case of accidental human exposure.
Corticosteroids, including BetaVet®, administered intra- articularly are systemically absorbed. Do not use in horses with acute infections.
Acute moderate to severe exacerbation of pain, further loss of joint motion, fever, or malaise within several days following intra-articular injection may
indicate a septic process. Because of the anti-inflammatory action of corticosteroids, signs of infection in the treated joint may be masked.
Due to the potential for exacerbation of clinical signs of laminitis, glucocorticoids should be used with caution in horses with a history of
laminitis, or horses otherwise at a higher risk for laminitis. Use with caution in horses with chronic nephritis, equine pituitary pars
intermedia dysfunction (PPID), and congestive heart failure.
Concurrent use of other anti-inflammatory drugs, such as NSAIDs or other corticosteroids, should be approached with caution. Due to the potential
for systemic exposure, concomitant use of NSAIDs and corticosteroids may increase the risk of gastrointestinal, renal, and other toxicity.
Consider appropriate wash out times prior to administering additional NSAIDs or corticosteroids.
Adverse reactions reported during a field study of 239 horses of various breeds which had been administered either BetaVet®
(n=119) or a saline control (n=120) at five percent (5%) and above were: acute joint effusion and/or local injection site swelling
(within 2 days of injection), 15% BetaVet® and 13% saline control; increased lameness (within the first 5 days), 6.7% BetaVet® and
8.3% saline control; loose stool, 5.9% BetaVet® and 8.3% saline control; increased heat in joint, 2.5% BetaVet® and 5% saline control;
and depression, 5.9% BetaVet® and 1.6% saline control.
DOSAGE AND ADMINISTRATION:
Shake well immediately before use. Use immediately after opening, then discard any remaining contents.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.